| Title | Breast Cancer Research and Treatment |
| Abbreviation | Breast Cancer Res. Treat. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Oncology (Q1); Cancer Research (Q2) |
| h-index | 171 |
| Overall Rank/Ranking | 2281 |
| SCImago Journal Rank (SJR) | 1.442 |
| Impact Score | 3.49 |
| Publisher | Springer New York |
| Country | United States |
| ISSN | 01676806, 15737217 |
| Best Quartile | Q1 |
| Coverage History | 1981-2022 |
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a `market place for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.
Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology.
Breast Cancer Research and Treatment is a journal covering the technologies/fields/categories related to Oncology (Q1); Cancer Research (Q2). It is published by Springer New York. The overall rank of Breast Cancer Research and Treatment is 2281. According to SCImago Journal Rank (SJR), this journal is ranked 1.442. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 171. The best quartile for this journal is Q1.
The ISSN of Breast Cancer Research and Treatment journal is 01676806, 15737217. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Breast Cancer Research and Treatment is cited by a total of 5595 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Breast Cancer Research and Treatment is 3.49, which is computed in 2023 as per its definition. Breast Cancer Research and Treatment IF is decreased by a factor of 0.57 and approximate percentage change is -14.04% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Breast Cancer Research and Treatment is 3.49. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.49 |
| 2021 | 4.06 |
| 2020 | 4.09 |
| 2019 | 3.54 |
| 2018 | 3.32 |
| 2017 | 3.66 |
| 2016 | 3.85 |
| 2015 | 4.39 |
| 2014 | 4.45 |
Breast Cancer Research and Treatment has an h-index of 171. It means 171 articles of this journal have more than 171 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Breast Cancer Research and Treatment is 01676806, 15737217. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Breast Cancer Research and Treatment is 2281. According to SCImago Journal Rank (SJR), this journal is ranked 1.442. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.442 |
| 2021 | 1.407 |
| 2020 | 1.908 |
| 2019 | 1.905 |
| 2018 | 1.899 |
| 2017 | 2.066 |
| 2016 | 2.181 |
| 2015 | 2.432 |
| 2014 | 2.397 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2281 |
| 2021 | 2338 |
| 2020 | 1445 |
| 2019 | 1434 |
| 2018 | 1506 |
| 2017 | 1312 |
| 2016 | 1179 |
| 2015 | 989 |
| 2014 | 1003 |
Breast Cancer Research and Treatment is published by Springer New York. It's publishing house is located in United States. Coverage history of this journal is as following: 1981-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Breast Cancer Research and Treatment is Breast Cancer Res. Treat.. This abbreviation ('Breast Cancer Res. Treat.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q1); Cancer Research (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Breast Cancer Research and Treatment latest impact IF is 3.49. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 4.45 (2014) and 3.32 (2018), respectively, in the last 9 years. Moreover, its average IS is 3.87 in the previous 9 years.
The Breast Cancer Research and Treatment has an SJR (SCImago Journal Rank) of 1.442, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.432 in 2015 and the lowest being 1.407 in 2021. Furthermore, the average SJR of the Breast Cancer Research and Treatment over the previous 9-year period stands at 3.87.
The latest h-index of the Breast Cancer Research and Treatment is 171.
The Breast Cancer Research and Treatment is published by the Springer New York, with its country of publication being the United States.
The Breast Cancer Research and Treatment is currently ranked 2281 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 989 in 2015 and its lowest position of 2338 in 2021.
The standard ISO4 abbreviation for the Breast Cancer Research and Treatment is Breast Cancer Res. Treat..
Breast Cancer Research and Treatment is classified as a journal that the Springer New York publishes.
The Breast Cancer Research and Treatment encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Breast Cancer Research and Treatment is assigned the following International Standard Serial Numbers (ISSN): 01676806, 15737217.
The best quartile for the Breast Cancer Research and Treatment is Q1 (2022).
The Breast Cancer Research and Treatment coverage history can be summarized as follows: 1981-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 16018 | Thieme Medical Publishers Inc. | 37 | 0.65 |
| Qualitative Research | journal | 2108 | SAGE Publications Ltd | 86 | 3.97 |
| Marine Biology Research | journal | 13573 | Taylor and Francis Ltd. | 42 | 1.06 |
| Journal, Indian Academy of Clinical Medicine | journal | 24608 | Indian Academy of Clinical Medicine | 16 | 0.06 |
| Tekstilec | trade journal | 19217 | Faculty of Natural Sciences and Engineering, Tekstilec | 14 | 0.73 |
| International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS | conference and proceedings | 781 | Association for Computing Machinery (ACM) | 100 | 8.01 |
| Asian Textile Journal | trade journal | 27455 | G P S Kwatra | 10 | 0.01 |
| Oral Radiology | journal | 9461 | Springer Japan | 20 | 2.06 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 | |
| International Journal of Advertising | journal | 1226 | Taylor and Francis Ltd. | 74 | 8.22 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.49 |
| 2021 | 4.06 |
| 2020 | 4.09 |
| 2019 | 3.54 |
| 2018 | 3.32 |
| 2017 | 3.66 |
| 2016 | 3.85 |
| 2015 | 4.39 |
| 2014 | 4.45 |
